The effects of breast cancer diagnosis and surgery on cognitive functions

References

• Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581–92.
   PubMed Web of Science ®Google Scholar
• Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007;11:6–15.
   PubMed Web of Science ®Google Scholar
• Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjöden PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 1991;27:1075–81.
   PubMed Web of Science ®Google Scholar
• Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 2004;100:2292–9.
   PubMed Web of Science ®Google Scholar
• Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, . Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175–83.
   PubMed Web of Science ®Google Scholar
• Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995;4:61–6.
   Web of Science ®Google Scholar
• van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, . Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210–8.
   PubMed Web of Science ®Google Scholar
• Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer – preliminary results of an observational longitudinal study. Breast 2005;14:142–50.
   PubMed Web of Science ®Google Scholar
• Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, . Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005;23:8025–32.
   PubMed Web of Science ®Google Scholar
• Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, . Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 2006;15: 422–30.
   PubMed Web of Science ®Google Scholar
• Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J 2008;14:396–400.
   PubMed Web of Science ®Google Scholar
• Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, . Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 2010;32:324–31.
   PubMed Web of Science ®Google Scholar
• Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623–9.
   PubMed Web of Science ®Google Scholar
• Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, . Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 2007;109: 1905–13.
   PubMed Web of Science ®Google Scholar
• Wefel JS , Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. ‘Chemobrain’ in breast carcinoma? Cancer 2004; 101:466–75.
   PubMedGoogle Scholar
• Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: A systematic review. Anesthesiology 2007;106:572–90.
   PubMed Web of Science ®Google Scholar
• Sauër AM, Kalkman C, van Dijk D. Postoperative cognitive decline. J Anesth 2009;23:256–9.
   PubMed Web of Science ®Google Scholar
• Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L. What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004;5: 273–82.
   PubMed Web of Science ®Google Scholar
• Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J. Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 2002;17:458–76.
   PubMed Web of Science ®Google Scholar
• Erlanger D, Feldman D, Kutner K, Kaushik T, Kroger H, Festa J, . Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making. Arch Clin Neuropsychol 2003;18: 293–316.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893–7.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, . The European Organization for Research and Treatment of Cancer qlq-c30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer-Verlag New York Inc.; 2009.
   Google Scholar
• Hedeker D, Gibbons RD. Longitudinal data analysis. New York: John Wiley & Sons Ltd; 2006.
   Google Scholar
• Leyland AH, Goldstein H. Multilevel modelling of health statistics. Chichester: John Wiley & Sons Ltd; 2001.
   Google Scholar
• Littell RC, Milliken GA, Stroup WW. SAS for mixed models. 2nd. New York: SAS Publishing; 2006.
   Google Scholar
• Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006;98:1742–5.
   PubMed Web of Science ®Google Scholar
• Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, . A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:828–34.
   PubMed Web of Science ®Google Scholar
• Vardy J, Wong K, Yi QL, Park A, Maruff P, Wagner L, . Assessing cognitive function in cancer patients. Support Care Cancer 2006;14:1111–8.
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, . Computerized reaction time battery versus a traditional neuropsychological battery: Detecting hiv-related impairments. J Int Neuropsychol Soc 2003;9:64–71.
   PubMed Web of Science ®Google Scholar
• Zehnder AE, Bläsi S, Berres M, Spiegel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? Am J Alzheimers Dis Other Demen 2007;22:416–26.
   PubMedGoogle Scholar
• Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Res Treat 2009;116:113–23.
   PubMed Web of Science ®Google Scholar
• Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: Conceptual and assessment issues. Psychosomatics 2002;43:259–81.
   PubMed Web of Science ®Google Scholar
• Lezak MD. Neuropsychological assessment. 4th. New York: Oxford University Press; 2004.
   Google Scholar
• Braver TS, Barch DM. A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev 2002; 26:809–17.
   PubMed Web of Science ®Google Scholar